Biotech: Biomarkers And The Future Of Cancer Drug Development

In An Effort To Bring More Diversified Content To Our Readers.....Welcome Our New Authors To KSMT.....BreakoutTrader, TIPSTER, and Ryan Canady......Profiles Can Be Viewed On Right Column

TIPSTER: Eurogeddon Fatigue – One Week To Save The Euro… Again

Quote of the Day: …liabilities and controls go together… Angela Merkel Macro Overview Squeaky Bum Time – Again One week to save the Euro, that’s what Italian Technocrat-Prime-Minister, Mario Monti, thinks. He is of course referring to the week which ...

Click To Read Full Article

Napodano: Zipsor A Nice Fit For Depomed

On June 21, 2012, Depomed (DEPO) announced the acquisition of the product Zipsor (diclofenac potassium) Liquid Filled Capsules from privately-held Xanodyne Pharmaceuticals, Inc. Zipsor is a non-steroidal anti-inflammatory drug (NSAID) indicated for relief of mild ...

Click To Read Full Article

Fiscal Cliff Deal: $41 in tax increases to $1 in spending cuts!

It appears we (Our Govt and the majority of voters) have not learned anything from history, even if it's only about 15 years old. The most recent fiscal cliff deal, reviewed by the CBO, has ...

Click To Read Full Article

No Weekly Trader Homework This Week

Due to time constraints this week, this is the best I could get done for everyone. As most of you know, I am now a restaurant owner and spending significant amounts of time trying to ...

Click To Read Full Article

Can Rick Santelli Teach President Obama Basic Math?

Chicago's Rick Santelli discusses another way to view the budget with the most simplified view I have seen so far. As I always say, Santelli is a voice of reason on major media television that ...

Click To Read Full Article

TIPSTER: Hollande – The New Canary In The Eurozone Mine

Quote of the Day: No one is preventing Hollande going ahead with joint bonds for France and Monti for Italy Michael Meister – Merkel’s Christian Democratic Union Party Member Macro Overview Hollande Is The Canary In The Eurozone Mine Did ...

Click To Read Full Article

Senator Marco Rubio To President Obama: Raising The Debt Ceiling A Sixth Time?

Another open letter to President Obama has gone viral among the masses via social media. First it was Leon Cooperman's letter to President Obama that was highly discussed, now it is Senator Marco Rubio expressing ...

Click To Read Full Article

Napodano: Nile Digs In

On May 15, 2012, Nile Therapeutics (NLTX) reported financial results for the first quarter 2012. The company reported grant revenues of $195K in the quarter. Net loss for the quarter was $0.8 million or $0.02 ...

Click To Read Full Article

Trading Lesson: Buy Winners, Not Losers

Remember this basic strategy to save yourself from racking up big losses or holding lots of red and sweating it. We have multiple discussions in the live chat throughout the day. This point keeps coming ...

Click To Read Full Article

A Daytraders Strategy: Part 2 of 2

Continued from Part 1 of A Daytraders Strategy Another successful strategy I use to day trade is very similar to the one used in Part One. However, this strategy uses different indicators to lead the decision ...

Click To Read Full Article

36,000+ Following KSMT And GROWING! Click To Join For Free!

Biotech: Biomarkers And The Future Of Cancer Drug Development by Biotech Due Diligence | This entry was posted on Tuesday, January 24th, 2012 and filed under Stock Market Comments Off

Merck (MRK) was emphasizing the importance of cancer biomarkers in the R&D day presentation. See the chart below for the pipeline programs, indication, and biomarker strategy.

Author Pages

Topic Archives

Topic Archives

Stock Conversation

Shout Box! (NEW)


Name:
Email:
For:

Mail will not be published
(but it's used for avatar)

( Sending... )

Michael Kudrna

(Wednesday, Jun 12. 2013 2:31 PM)

For MikeC, Missed you in chat. For your stock, 10.50 is key support where I’d draw a line in the sand. Above 11.25 would likely make it run higher on a breakout. Currently it’s consolidating nicely with upside potential, but if it doesn’t break out on the first attempt, look for another pullback towards 10.75 area, above support, to possibly reload your position. Easy money seems to have been made, so keep expectations realistic. Hope that helps.

[reply]

Michael Kudrna

(Wednesday, Jun 5. 2013 9:39 AM)

Still no signs of a strong enough support level in GST to start adding more to the position. Will wait patiently to add, but $2 seems more and more likely as it drifts lower

[reply]

Michael Kudrna

(Tuesday, Jun 4. 2013 10:54 AM)

watching and looking to add another increment in GST around 2.44 as it seems to have found short-term stability

[reply]

Michael Kudrna

(Monday, May 20. 2013 11:10 AM)

Keeping tight position in DEJ until we get confirmation of no short-term dilution from management. As Zacks noted, cash ratio is slightly under what they need to keep financing.

[reply]

Michael Kudrna

(Friday, May 17. 2013 12:56 PM)

Added back to GST and looking for the chart to grind higher. Easy money seems to be made, so keep a close eye on your positions.

[reply]